Background Evaluation and interpretation of the literature on obstructive sleep apnea (OSA)
allows for consolidation and determination of the key factors important for clinical …

Objective To perform a systematic review and meta-analysis for studies evaluating
hypoglossal nerve stimulation (HNS) clinical outcomes in the treatment of moderate to …

Objective To describe the 36-month clinical and polysomnography (PSG) outcomes in an
obstructive sleep apnea (OSA) cohort treated with hypoglossal cranial nerve upper airway …

Obstructive sleep apnoea is a challenging medical problem due to its prevalence, its impact
on quality of life and performance in school and professionally, the implications for risk of …

Obstructive sleep apnea (OSA) syndrome is increasingly common among middle aged and
older adults and is frequently linked to most cardiovascular diseases (CVD). Sleep …

Obstructive sleep apnea (OSA) is a worldwide disease whose prevalence is increasing as
obesity rates increase. The link between obesity and OSA is likely to be the deposition of fat …

BACKGROUND: The rising prevalence and associated public health burden of obesity has
led to advancements in pharmaceuticals for weight management. Semaglutide 2.4 mg, an …

Continuous positive airway pressure (CPAP) is the standard treatment for moderate‐to‐
severe obstructive sleep apnoea (OSA). However, adherence to CPAP is limited and non …

Objectives: Obstructive sleep apnea (OSA) is a prevalent disease with significant health
impacts. While first line therapy is CPAP, long-term compliance is low and device misuse is …

Smart implants are increasingly used to treat various diseases, track patient status, and
restore tissue and organ function. These devices support internal organs, actively stimulate …